The previously non-controlled anesthetic Propofol would be listed in schedule IV under a Drug Enforcement Administration proposal (75 Fed. Reg. 66195; Oct. 27, 2010). Propofol was approved for marketing in the United States in 1989 as an ultra-short acting intravenous anesthetic under the trade name Diprivan™. Generic Propofol is also marketed as a veterinary drug under the names,... Read More